Showing 1821-1830 of 4267 results for "".
Home Devices: Do They Actually Work?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-devices-do-they-actually-work/21334/Although home devices may appeal to patients due to their convenience, often they fall short when it comes to sound science and optimal outcomes.Tazarotene Lotion for Acne
https://practicaldermatology.com/topics/acne-rosacea/tazarotene-lotion-for-acne/23388/Tazarotene Lotion 0.045% offers dermatologists a new option that is effective and well tolerated for treating acne.Currents: Managing Hair Disorders
https://practicaldermatology.com/topics/hair-nails/currents-managing-hair-disorders/23230/The Skinny on Non-Invasive Fat Reduction: The Case for an a la Carte Approach to Body Contouring
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-skinny-on-non-invasive-fat-reduction-the-case-for-an-a-la-carte-approach-to-body-contouring/20978/As the business of body contouring explodes, physicians—and patients—must consider the treatment options.EHR User Series: The Search for EHR Mobility
https://practicaldermatology.com/topics/practice-management/ehr-user-series-the-search-for-ehr-mobility/21225/In the electronic age, a truly mobile EHR may be key in the pursuit of fast, efficient medical care.Financial Benchmarking Update for Dermatology Practices
https://practicaldermatology.com/topics/practice-management/financial-benchmarking-update-for-dermatology-practices/21621/Successful practices use benchmarking to compare their performance to others, assess their own performance over time, and plan for the long term.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21848/Preparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuBiologics and Beyond
https://practicaldermatology.com/topics/psoriasis/biologics-and-beyond/23554/A look at off-label use of biologics and JAK inhibitors.